Regulation of human cranial osteoblast phenotype by FGF-2, FGFR-2 and BMP-2 signaling

Histology and Histopathology

Volumn 17, Issue 3, 2002, Pages 877-885

  Marie, Pierre J ^a   Debiais, F ^a   Hay E ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

BMP 2; Calvaria; FGF 2; Human; Osteoblasts; Osteogenesis; Signaling; Suture

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 2; NERVE CELL ADHESION MOLECULE; PROTEIN KINASE C; PROTEIN TYROSINE KINASE;

ACROCEPHALOSYNDACTYLY; APOPTOSIS; BONE DEVELOPMENT; CALVARIA; CELL DIFFERENTIATION; CELL PROLIFERATION; HUMAN; HUMAN CELL; MESENCHYME CELL; OSSIFICATION; OSTEOBLAST; OSTEOGENESIS IMPERFECTA; PHENOTYPE; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SKULL; SKULL SUTURE;

APOPTOSIS; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELL DIVISION; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION; HUMANS; MODELS, BIOLOGICAL; OSTEOBLASTS; PHENOTYPE; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; RECEPTORS, FIBROBLAST GROWTH FACTOR; SIGNAL TRANSDUCTION; SKULL; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0036061947     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (69)

1. Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand
2. Apoptotic cell death during normal embryogenesis of the coronal suture: Early detection of apoptosis in mice using annexin V
3. Fibroblast growth factor receptors: Lessons from the genes
4. Human osteoblasts express a repertoire of cadherins, which are critical for BMP-2-induced osteogenic differentiation
5. Cell-cell communication in bone
6. Transforming growth factor beta and fibroblast growth factors and their receptors: Role in sutural biology and craniosynostosis
7. Increased bone formation and osteoblastic cell phenotype in premature cranial suture ossification (craniosynostosis)
8. Increased bone formation and osteoblastic cell phenotype in craniosynostosis
9. Age-related changes in bone formation, osteoblastic cell proliferation and differentiation during postnatal osteogenesis in human calvaria
10. The effects of fibroblast growth factor-2 on human neonatal calvaria osteoblastic cells are differentiation stage specific
11. Fibroblast Growth Factor-2 (FGF-2) increases N-cadherin expression through protein kinase C and src-kinase pathways in human calvaria osteoblasts
12. Protein kinase C-dependent upregulation of N-cadherin expression by phorbol ester in human calvaria osteoblasts
13. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation
14. Mutations of the TWIST gene in the Saethre-Chotzen syndrome
15. A role of N-cadherin in the development of the differentiated osteoblastic phenotype
16. Decreased proliferation and altered differentiation in osteoblasts from genetically and clinically distinct craniosynostotic disorders
17. Complexity of FGF receptors: Genetic basis for structural diversity and functional specificity
18. Chondrogenic differentiation of murine C3H10T1/2 multipotential mesenchymal cells: II. Stimulation by bone morphogenetic protein-2 requires modulation of N-cadherin expression and function
19. All for one and one for all: Condensations and the initiation of skeletal development
20. Effects of bone morphogenetic protein-2 on human neonatal calvaria cell differentiation
21. N- and E-cadherin mediate early human calvaria osteoblast differentiation promoted by bone morphogenetic protein-2
22. Bone morphogenetic protein-2 promotes osteoblast apoptosis through a Smad-independent, protein kinase C-dependent signaling pathway
23. Craniosynostosis syndromes: From genes to premature fusion of skull bones
24. TGF-beta signalling from cell membrane to nucleus through SMAD proteins
25. Fibroblast growth factors and FGF receptor families in bone
26. Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome
27. Fgfr1 and Fgfr2 have distinct differentiation- and proliferation-related roles in the developing mouse skull vault
28. A mutation in the homeodomain of the human MSX2 gene in a family affected with autosomal dominant craniosynostosis
29. Fibroblast growth factor receptor kinases: Molecular analysis and signal transduction
30. Role of Cbfa1 in osteoblast differentiation and function
31. FGF-, BMP- and Shh-mediated signaling pathways in the regulation cranial suture morphogenesis and calvaria bone development
32. The Ser252Trp fibroblast growth factor receptor-2 (FGFR-2) mutation induces PKC-independent downregulation of FGFR-2 associated with premature calvaria osteoblast differentiation
33. Role of N-cadherin and protein kinase C in osteoblast gene activation induced by the S252W fibroblast growth factor receptor 2 mutation in Apert craniosynostosis
34. Increased osteoblast apoptosis in Apert craniosynostosis: Role of protein kinase C and interleukin-1
35. Expression of PTHrP and PTH/PTHrP receptor in newborn human calvaria osteoblastic cells
36. Increased calvaria cell differentiation and bone matrix formation induced by fibroblast growth factor receptor-2 mutations in Apert syndrome
37. Identification of genes induced by the Ser252Trp FGFR-2 Apert mutation in osteoblast using atlas human expression arrays: Evidence for increased expression of PKCa, IL-1a and RhoA GTPase
38. Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis
39. Signaling by fibroblast growth factor (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts
40. Msx2 is a transcriptional regulator in the BMP4-mediated programmed cell death pathway
41. Regulation of endosteal bone formation and osteoblasts in rodent vertebrate
42. Human osteoblastic cells: Relationship with bone formation
43. Effects of bone morphogenetic proteins on cells of the osteoblastic lineage
44. Cellular and molecular alterations of osteoblasts in human disorders of bone formation
45. Osteoblasts and bone formation
46. The molecular genetics of bone formation: Implications for therapeutic interventions in bone disorders
47. Role of N-cadherin in bone formation
48. Fibroblast growth factors and osteoblasts
49. Genetic control of the cell proliferation-differentiation balance in the developing skull vault: Roles of fibroblast growth factor receptor signalling pathways
50. Studies in cranial suture biology: Upregulation of transforming growth factor-β1 and basic fibroblast growth factor mRNA correlates with posterior frontal cranial suture fusion in the rat
51. Fibroblast growth-factor receptor mutations in human skeletal disorders
52. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia
53. FGF signaling in skeletal development
54. Cranial sutures as intramembranous bone growth sites
55. Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specify
56. Apoptosis in murine calvarial bone and suture development
57. Activating mutations in the extracellular domain of the fibroblast growth factor 2 function by disryption of the disulfide bond in the third immunoglobulin-like domain
58. Enhanced activity of osteoblast differentiation factor (PEBP2alphaA2/CBFa1) in affected sutural osteoblasts from patients with nonsyndromic craniosynostosis
59. Cadherins: A molecular family important in selective cell-cell adhesion
60. Bone morphogenetic protein: The molecularization of skeletal system development
61. Fibroblast growth factor receptors have different signaling and mitogenic potentials
62. Functions of fibroblast growth factors and their receptors
63. Functional haploinsufficiency of the human homebox gene MSX2 causes defects in skull ossification
64. The bone morphogenetic protein family and osteogenesis
65. Regulation of osteoblast differentiation mediated by bone morphogenetic protiens, hedgehogs, and Cbfa1
66. Increased bone formation and decreased osteocalcin expression induced by reduced twist dosage in Saethre-Chotzen syndrome
67. Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome
68. Uncoupling fibroblast growth factor receptor 2 ligand binding specificity leads to Aper syndrome-like phenotypes